VEON(VEON)
VEON
Q4 2026 EPS Estimate
$1.61
Nov 11, 2026 · Reports before open
Revenue Estimate
$1.30B
FY2026E EPS$6.89
FY2027E EPS$8.52
Analyst Sentiment
Wall St. Consensus
Buy13 analysts·Moderate coverage
69
Score
10 Buy (77%)3 Hold (23%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1077%
Hold
323%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$70.00
+15.9%
Consensus
$72.00
+19.2%
Bull
$74.00
+22.5%
12-Month Target Range13 analysts
$70.00$72.00$74.00
Current $60.40Consensus
Current Price
$60.40
Upside to Consensus
$11.60
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.28%
EPS+23.65%
FY2028
Rev+10.20%
EPS+25.27%
FY2029
Rev+8.60%
EPS+23.65%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $5.08B | $5.45B | $6.01B | $6.52B | $6.71B |
| Low | $5.07B | $5.30B | $5.61B | $6.34B | $6.52B |
| High | $5.10B | $5.56B | $6.31B | $6.66B | $6.85B |
| EBITDA Avg | $2.18B | $2.34B | $2.57B | $2.79B | $2.88B |
| Low | $2.17B | $2.27B | $2.40B | $2.72B | $2.79B |
| High | $2.19B | $2.38B | $2.70B | $2.85B | $2.94B |
| EBIT Avg | $1.33B | $1.42B | $1.57B | $1.70B | $1.75B |
| Low | $1.32B | $1.38B | $1.46B | $1.66B | $1.70B |
| High | $1.33B | $1.45B | $1.65B | $1.74B | $1.79B |
| Net Income Avg | $497M | $598M | $709M | $947M | $1.11B |
| Low | $484M | $589M | $627M | $912M | $1.07B |
| High | $504M | $628M | $872M | $972M | $1.14B |
| EPS Avg | $6.89 | $8.52 | $10.67 | $13.19 | $15.49 |
| Low | $6.75 | $8.20 | $8.73 | $12.71 | $14.92 |
| High | $7.02 | $8.74 | $12.15 | $13.55 | $15.90 |
| Analysts (Rev / EPS) | 4 / 4 | 4 / 4 | 5 / 5 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $1.30B | $1.32B |
| Low | $1.28B | $1.31B |
| High | $1.31B | $1.33B |
| EBITDA Avg | $556M | $567M |
| Low | $550M | $560M |
| High | $560M | $571M |
| EBIT Avg | $339M | $346M |
| Low | $335M | $342M |
| High | $341M | $348M |
| Net Income Avg | $114M | $119M |
| Low | $112M | $117M |
| High | $115M | $120M |
| EPS Avg | $1.60 | $1.68 |
| Low | $1.58 | $1.65 |
| High | $1.62 | $1.69 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |